OBJECTIVES: This experiment determined the safety and tolerability of intranasal cocaine during aripiprazole maintenance. METHODS:Six cocaine-dependent human subjects were maintained on aripiprazole (15 mg) and placebo for 10 days in counterbalanced order prior to assessing the physiological and subject-rated effects of intranasal cocaine. RESULTS:Intranasal cocaine produced prototypical stimulant-like effects (e.g., increased blood pressure and heart rate, increased subject ratings of Like Drug and Stimulated), and aripiprazole enhanced these effects on several measures. CONCLUSIONS:Aripiprazole (15 mg/day) is safe and tolerable when combined with cocaine; however, the usefulness of aripiprazole as a treatment for cocaine-use disorders remains to be determined.
RCT Entities:
OBJECTIVES: This experiment determined the safety and tolerability of intranasal cocaine during aripiprazole maintenance. METHODS: Six cocaine-dependent human subjects were maintained on aripiprazole (15 mg) and placebo for 10 days in counterbalanced order prior to assessing the physiological and subject-rated effects of intranasal cocaine. RESULTS: Intranasal cocaine produced prototypical stimulant-like effects (e.g., increased blood pressure and heart rate, increased subject ratings of Like Drug and Stimulated), and aripiprazole enhanced these effects on several measures. CONCLUSIONS:Aripiprazole (15 mg/day) is safe and tolerable when combined with cocaine; however, the usefulness of aripiprazole as a treatment for cocaine-use disorders remains to be determined.
Authors: John M Kane; William H Carson; Anutosh R Saha; Robert D McQuade; Gary G Ingenito; Dan L Zimbroff; Mirza W Ali Journal: J Clin Psychiatry Date: 2002-09 Impact factor: 4.384
Authors: Paul W Czoty; H Donald Gage; Pradeep K Garg; Sudha Garg; Michael A Nader Journal: Psychopharmacology (Berl) Date: 2013-09-29 Impact factor: 4.530
Authors: Landhing M Moran; Karran A Phillips; William J Kowalczyk; Udi E Ghitza; Daniel A Agage; David H Epstein; Kenzie L Preston Journal: Behav Pharmacol Date: 2017-02 Impact factor: 2.293
Authors: Nestor Szerman; Ignacio Basurte-Villamor; Pablo Vega; Jose Martinez-Raga; Carlos Parro-Torres; Julia Cambra Almerge; Lara Grau-López; Mario De Matteis; Francisco Arias Journal: Drugs Real World Outcomes Date: 2020-03